-
1
-
-
77953892400
-
Molecular mechanisms of neurodegeneration in Alzheimer's disease
-
Crews L, Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet 2010; 19(R1): R12–20
-
(2010)
Hum Mol Genet
, vol.19
, Issue.R1
, pp. R12-20
-
-
Crews, L.1
Masliah, E.2
-
2
-
-
0025863618
-
Neuropathological stageing of Alzheimer-related changes
-
Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239–59
-
(1991)
Acta Neuropathol
, vol.82
, pp. 239-259
-
-
Braak, H.1
Braak, E.2
-
3
-
-
0037172826
-
Phases of A beta-deposition in the human brain and its relevance for the development of AD
-
Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002; 58: 1791–800
-
(2002)
Neurology
, vol.58
, pp. 1791-1800
-
-
Thal, D.R.1
Rub, U.2
Orantes, M.3
Braak, H.4
-
4
-
-
77955364852
-
Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies–a review
-
Ariga T, Miyatake T, Yu RK. Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies–a review. J Neurosci Res 2010; 88: 2303–15
-
(2010)
J Neurosci Res
, vol.88
, pp. 2303-2315
-
-
Ariga, T.1
Miyatake, T.2
Yu, R.K.3
-
5
-
-
77949724546
-
beta-Amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease
-
Genedani S, Agnati LF, Leo G, Buzzega D, Maccari F, Carone C, Andreoli N, Filaferro M, Volpi N. beta-Amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 2010; 7: 150–7
-
(2010)
Curr Alzheimer Res
, vol.7
, pp. 150-157
-
-
Genedani, S.1
Agnati, L.F.2
Leo, G.3
Buzzega, D.4
Maccari, F.5
Carone, C.6
Andreoli, N.7
Filaferro, M.8
Volpi, N.9
-
6
-
-
11144221004
-
Amyloid accomplices and enforcers
-
Alexandrescu AT. Amyloid accomplices and enforcers. Protein Sci 2005; 14: 1–12
-
(2005)
Protein Sci
, vol.14
, pp. 1-12
-
-
Alexandrescu, A.T.1
-
7
-
-
0042703654
-
Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit
-
Ancsin JB. Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit. Amyloid 2003; 10: 67–79
-
(2003)
Amyloid
, vol.10
, pp. 67-79
-
-
Ancsin, J.B.1
-
8
-
-
0027180087
-
Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease
-
Brandan E, Inestrosa NC. Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease. Gen Pharmacol 1993; 24: 1063–8
-
(1993)
Gen Pharmacol
, vol.24
, pp. 1063-1068
-
-
Brandan, E.1
Inestrosa, N.C.2
-
9
-
-
33947164895
-
Focal adhesions regulate Abeta signaling and cell death in Alzheimer's disease
-
Caltagarone J, Jing Z, Bowser R. Focal adhesions regulate Abeta signaling and cell death in Alzheimer's disease. Biochim Biophys Acta 2007; 1772: 438–45
-
(2007)
Biochim Biophys Acta
, vol.1772
, pp. 438-445
-
-
Caltagarone, J.1
Jing, Z.2
Bowser, R.3
-
10
-
-
0001130066
-
Alzheimer's disease and heparan sulfate proteoglycan
-
Fukuchi K, Hart M, Li L. Alzheimer's disease and heparan sulfate proteoglycan. Front Biosci 1998; 3: d327–37
-
(1998)
Front Biosci
, vol.3
, pp. d327-d337
-
-
Fukuchi, K.1
Hart, M.2
Li, L.3
-
12
-
-
77950679263
-
Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw
-
Ajmo JM, Bailey LA, Howell MD, Cortez LK, Pennypacker KR, Mehta HN, Morgan D, Gordon MN, Gottschall PE. Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw. J Neurochem 2010; 113: 784–95
-
(2010)
J Neurochem
, vol.113
, pp. 784-795
-
-
Ajmo, J.M.1
Bailey, L.A.2
Howell, M.D.3
Cortez, L.K.4
Pennypacker, K.R.5
Mehta, H.N.6
Morgan, D.7
Gordon, M.N.8
Gottschall, P.E.9
-
13
-
-
12244260372
-
Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease
-
Sykova E, Vorisek I, Antonova T, Mazel T, Meyer-Luehmann M, Jucker M, Hajek M, Ort M, Bures J. Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease. Proc Natl Acad Sci U S A 2005; 102: 479–84
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 479-484
-
-
Sykova, E.1
Vorisek, I.2
Antonova, T.3
Mazel, T.4
Meyer-Luehmann, M.5
Jucker, M.6
Hajek, M.7
Ort, M.8
Bures, J.9
-
14
-
-
78649737455
-
The extracellular matrix at a glance
-
Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci 2010; 123(Pt 24): 4195–200
-
(2010)
J Cell Sci
, vol.123
, pp. 4195-4200
-
-
Frantz, C.1
Stewart, K.M.2
Weaver, V.M.3
-
15
-
-
84884592784
-
Pathophysiology of the brain extracellular matrix: a new target for remyelination
-
Lau LW, Cua R, Keough MB, Haylock-Jacobs S, Yong VW. Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat Rev Neurosci 2013; 14: 722–9
-
(2013)
Nat Rev Neurosci
, vol.14
, pp. 722-729
-
-
Lau, L.W.1
Cua, R.2
Keough, M.B.3
Haylock-Jacobs, S.4
Yong, V.W.5
-
16
-
-
77951234989
-
The extracellular matrix in development and morphogenesis: a dynamic view
-
Rozario T, DeSimone DW. The extracellular matrix in development and morphogenesis: a dynamic view. Dev Biol 2010; 341: 126–40
-
(2010)
Dev Biol
, vol.341
, pp. 126-140
-
-
Rozario, T.1
DeSimone, D.W.2
-
17
-
-
84900304808
-
Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders
-
Farach-Carson MC, Warren CR, Harrington DA, Carson DD. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biol 2014; 34: 64–79
-
(2014)
Matrix Biol
, vol.34
, pp. 64-79
-
-
Farach-Carson, M.C.1
Warren, C.R.2
Harrington, D.A.3
Carson, D.D.4
-
18
-
-
0034490621
-
PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis
-
Wong CW, Wiedle G, Ballestrem C, Wehrle-Haller B, Etteldorf S, Bruckner M, Engelhardt B, Gisler RH, Imhof BA. PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis. Mol Biol Cell 2000; 11: 3109–21
-
(2000)
Mol Biol Cell
, vol.11
, pp. 3109-3121
-
-
Wong, C.W.1
Wiedle, G.2
Ballestrem, C.3
Wehrle-Haller, B.4
Etteldorf, S.5
Bruckner, M.6
Engelhardt, B.7
Gisler, R.H.8
Imhof, B.A.9
-
19
-
-
84869500245
-
Localized tensional forces on PECAM-1 elicit a global mechanotransduction response via the integrin-RhoA pathway
-
Collins C, Guilluy C, Welch C, O'Brien ET, Hahn K, Superfine R, Burridge K, Tzima E. Localized tensional forces on PECAM-1 elicit a global mechanotransduction response via the integrin-RhoA pathway. Curr Biol 2012; 22: 2087–94
-
(2012)
Curr Biol
, vol.22
, pp. 2087-2094
-
-
Collins, C.1
Guilluy, C.2
Welch, C.3
O'Brien, E.T.4
Hahn, K.5
Superfine, R.6
Burridge, K.7
Tzima, E.8
-
20
-
-
84860878530
-
Age related changes of the extracellular matrix and stem cell maintenance
-
Kurtz A, Oh SJ. Age related changes of the extracellular matrix and stem cell maintenance. Prev Med 2012; 54(Suppl.): S50–6
-
(2012)
Prev Med
, vol.54
, pp. S50-S56
-
-
Kurtz, A.1
Oh, S.J.2
-
21
-
-
84922322731
-
ECM in brain aging and dementia
-
Morawski M, Filippov M, Tzinia A, Tsilibary E, Vargova L. ECM in brain aging and dementia. Prog Brain Res 2014; 214: 207–27
-
(2014)
Prog Brain Res
, vol.214
, pp. 207-227
-
-
Morawski, M.1
Filippov, M.2
Tzinia, A.3
Tsilibary, E.4
Vargova, L.5
-
22
-
-
77958492330
-
The dual role of the extracellular matrix in synaptic plasticity and homeostasis
-
Dityatev A, Schachner M, Sonderegger P. The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat Rev Neurosci 2010; 11: 735–46
-
(2010)
Nat Rev Neurosci
, vol.11
, pp. 735-746
-
-
Dityatev, A.1
Schachner, M.2
Sonderegger, P.3
-
23
-
-
77958193306
-
Compartmentalization from the outside: the extracellular matrix and functional microdomains in the brain
-
Dityatev A, Seidenbecher CI, Schachner M. Compartmentalization from the outside: the extracellular matrix and functional microdomains in the brain. Trends Neurosci 2010; 33: 503–12
-
(2010)
Trends Neurosci
, vol.33
, pp. 503-512
-
-
Dityatev, A.1
Seidenbecher, C.I.2
Schachner, M.3
-
24
-
-
79955644788
-
Molecular signals of plasticity at the tetrapartite synapse
-
Dityatev A, Rusakov DA. Molecular signals of plasticity at the tetrapartite synapse. Curr Opin Neurobiol 2011; 21: 353–9
-
(2011)
Curr Opin Neurobiol
, vol.21
, pp. 353-359
-
-
Dityatev, A.1
Rusakov, D.A.2
-
25
-
-
0037704306
-
Extracellular matrix molecules and synaptic plasticity
-
Dityatev A, Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat Rev Neurosci 2003; 4: 456–68
-
(2003)
Nat Rev Neurosci
, vol.4
, pp. 456-468
-
-
Dityatev, A.1
Schachner, M.2
-
26
-
-
0029583225
-
Increased collagen content of cerebral microvessels in Alzheimer's disease
-
Kalaria RN, Pax AB. Increased collagen content of cerebral microvessels in Alzheimer's disease. Brain Res 1995; 705: 349–52
-
(1995)
Brain Res
, vol.705
, pp. 349-352
-
-
Kalaria, R.N.1
Pax, A.B.2
-
27
-
-
0033944494
-
Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease
-
Farkas E, De Jong GI, de Vos RA, Jansen Steur EN, Luiten PG. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. Acta Neuropathol 2000; 100: 395–402
-
(2000)
Acta Neuropathol
, vol.100
, pp. 395-402
-
-
Farkas, E.1
De Jong, G.I.2
de Vos, R.A.3
Jansen Steur, E.N.4
Luiten, P.G.5
-
28
-
-
4644327998
-
Increase of white matter string vessels in Alzheimer's disease
-
discussion 443–9
-
Challa VR, Thore CR, Moody DM, Anstrom JA, Brown WR. Increase of white matter string vessels in Alzheimer's disease. J Alzheimers Dis 2004; 6: 379–83; discussion 443–9
-
(2004)
J Alzheimers Dis
, vol.6
, pp. 379-383
-
-
Challa, V.R.1
Thore, C.R.2
Moody, D.M.3
Anstrom, J.A.4
Brown, W.R.5
-
30
-
-
33646099167
-
Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen
-
Tian J, Shi J, Smallman R, Iwatsubo T, Mann DM. Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Neuropathol Appl Neurobiol 2006; 32: 332–40
-
(2006)
Neuropathol Appl Neurobiol
, vol.32
, pp. 332-340
-
-
Tian, J.1
Shi, J.2
Smallman, R.3
Iwatsubo, T.4
Mann, D.M.5
-
31
-
-
0025223441
-
Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome
-
Snow AD, Mar H, Nochlin D, Sekiguchi RT, Kimata K, Koike Y, Wight TN. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 1990; 137: 1253–70
-
(1990)
Am J Pathol
, vol.137
, pp. 1253-1270
-
-
Snow, A.D.1
Mar, H.2
Nochlin, D.3
Sekiguchi, R.T.4
Kimata, K.5
Koike, Y.6
Wight, T.N.7
-
32
-
-
0029820953
-
Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction
-
Maresh GA, Erezyilmaz D, Murry CE, Nochlin D, Snow AD. Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction. J Neurochem 1996; 67: 1132–44
-
(1996)
J Neurochem
, vol.67
, pp. 1132-1144
-
-
Maresh, G.A.1
Erezyilmaz, D.2
Murry, C.E.3
Nochlin, D.4
Snow, A.D.5
-
33
-
-
70350426110
-
Molecular status of plasma fibronectin as an additional biomarker for assessment of Alzheimer's dementia risk
-
Lemanska-Perek A, Leszek J, Krzyzanowska-Golab D, Radzik J, Katnik-Prastowska I. Molecular status of plasma fibronectin as an additional biomarker for assessment of Alzheimer's dementia risk. Dement Geriatr Cogn Disord 2009; 28: 338–42
-
(2009)
Dement Geriatr Cogn Disord
, vol.28
, pp. 338-342
-
-
Lemanska-Perek, A.1
Leszek, J.2
Krzyzanowska-Golab, D.3
Radzik, J.4
Katnik-Prastowska, I.5
-
34
-
-
84919915106
-
Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts
-
Muenchhoff J, Poljak A, Song F, Raftery M, Brodaty H, Duncan M, McEvoy M, Attia J, Schofield PW, Sachdev PS. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts. J Alzheimers Dis 2015; 43: 1355–73
-
(2015)
J Alzheimers Dis
, vol.43
, pp. 1355-1373
-
-
Muenchhoff, J.1
Poljak, A.2
Song, F.3
Raftery, M.4
Brodaty, H.5
Duncan, M.6
McEvoy, M.7
Attia, J.8
Schofield, P.W.9
Sachdev, P.S.10
-
35
-
-
0023992201
-
Unchanged concentrations of plasma fibronectin in Alzheimer's disease
-
Rattan SI, Rasmussen LM, Bjerring P, Bhatia P, Clark BF. Unchanged concentrations of plasma fibronectin in Alzheimer's disease. J Clin Pathol 1988; 41: 476
-
(1988)
J Clin Pathol
, vol.41
, pp. 476
-
-
Rattan, S.I.1
Rasmussen, L.M.2
Bjerring, P.3
Bhatia, P.4
Clark, B.F.5
-
36
-
-
0034650797
-
Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis
-
Zanetta L, Marcus SG, Vasile J, Dobryansky M, Cohen H, Eng K, Shamamian P, Mignatti P. Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. Int J Cancer 2000; 85: 281–8
-
(2000)
Int J Cancer
, vol.85
, pp. 281-288
-
-
Zanetta, L.1
Marcus, S.G.2
Vasile, J.3
Dobryansky, M.4
Cohen, H.5
Eng, K.6
Shamamian, P.7
Mignatti, P.8
-
37
-
-
84892642276
-
Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease
-
Allen N, Robinson AC, Snowden J, Davidson YS, Mann DM. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease. Neuropathol Appl Neurobiol 2014; 40: 136–48
-
(2014)
Neuropathol Appl Neurobiol
, vol.40
, pp. 136-148
-
-
Allen, N.1
Robinson, A.C.2
Snowden, J.3
Davidson, Y.S.4
Mann, D.M.5
-
38
-
-
84913536488
-
Patterns of microglial cell activation in frontotemporal lobar degeneration
-
Lant SB, Robinson AC, Thompson JC, Rollinson S, Pickering-Brown S, Snowden JS, Davidson YS, Gerhard A, Mann DM. Patterns of microglial cell activation in frontotemporal lobar degeneration. Neuropathol Appl Neurobiol 2014; 40: 686–96
-
(2014)
Neuropathol Appl Neurobiol
, vol.40
, pp. 686-696
-
-
Lant, S.B.1
Robinson, A.C.2
Thompson, J.C.3
Rollinson, S.4
Pickering-Brown, S.5
Snowden, J.S.6
Davidson, Y.S.7
Gerhard, A.8
Mann, D.M.9
-
39
-
-
84856002055
-
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
-
Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 2012; 8: 1–13
-
(2012)
Alzheimers Dement
, vol.8
, pp. 1-13
-
-
Hyman, B.T.1
Phelps, C.H.2
Beach, T.G.3
Bigio, E.H.4
Cairns, N.J.5
Carrillo, M.C.6
Dickson, D.W.7
Duyckaerts, C.8
Frosch, M.P.9
Masliah, E.10
Mirra, S.S.11
Nelson, P.T.12
Schneider, J.A.13
Thal, D.R.14
Thies, B.15
Trojanowski, J.Q.16
Vinters, H.V.17
Montine, T.J.18
-
40
-
-
0025908356
-
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
-
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479–86
-
(1991)
Neurology
, vol.41
, pp. 479-486
-
-
Mirra, S.S.1
Heyman, A.2
McKeel, D.3
Sumi, S.M.4
Crain, B.J.5
Brownlee, L.M.6
Vogel, F.S.7
Hughes, J.P.8
van Belle, G.9
Berg, L.10
-
41
-
-
0025786506
-
Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease
-
Perry G, Siedlak SL, Richey P, Kawai M, Cras P, Kalaria RN, Galloway PG, Scardina JM, Cordell B, Greenberg BD, Ledbetter SR and Gambetti P. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. J Neurosci 1991; 11: 3679–83
-
(1991)
J Neurosci
, vol.11
, pp. 3679-3683
-
-
Perry, G.1
Siedlak, S.L.2
Richey, P.3
Kawai, M.4
Cras, P.5
Kalaria, R.N.6
Galloway, P.G.7
Scardina, J.M.8
Cordell, B.9
Greenberg, B.D.10
Ledbetter, S.R.11
Gambetti, P.12
-
42
-
-
0035157875
-
Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains
-
van Horssen J, Otte-Holler I, David G, Maat-Schieman ML, van den Heuvel LP, Wesseling P, de Waal RM, Verbeek MM. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. Acta Neuropathol 2001; 102: 604–14
-
(2001)
Acta Neuropathol
, vol.102
, pp. 604-614
-
-
van Horssen, J.1
Otte-Holler, I.2
David, G.3
Maat-Schieman, M.L.4
van den Heuvel, L.P.5
Wesseling, P.6
de Waal, R.M.7
Verbeek, M.M.8
-
43
-
-
0345008875
-
Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain
-
Verbeek MM, Otte-Holler I, van den Born J, van den Heuvel LP, David G, Wesseling P, de Waal RM. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am J Pathol 1999; 155: 2115–25
-
(1999)
Am J Pathol
, vol.155
, pp. 2115-2125
-
-
Verbeek, M.M.1
Otte-Holler, I.2
van den Born, J.3
van den Heuvel, L.P.4
David, G.5
Wesseling, P.6
de Waal, R.M.7
-
44
-
-
0034603407
-
Agrin and microvascular damage in Alzheimer's disease
-
Berzin TM, Zipser BD, Rafii MS, Kuo-Leblanc V, Yancopoulos GD, Glass DJ, Fallon JR, Stopa EG. Agrin and microvascular damage in Alzheimer's disease. Neurobiol Aging 2000; 21: 349–55
-
(2000)
Neurobiol Aging
, vol.21
, pp. 349-355
-
-
Berzin, T.M.1
Zipser, B.D.2
Rafii, M.S.3
Kuo-Leblanc, V.4
Yancopoulos, G.D.5
Glass, D.J.6
Fallon, J.R.7
Stopa, E.G.8
-
45
-
-
0024273721
-
The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease
-
Snow AD, Mar H, Nochlin D, Kimata K, Kato M, Suzuki S, Hassell J, Wight TN. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol 1988; 133: 456–63
-
(1988)
Am J Pathol
, vol.133
, pp. 456-463
-
-
Snow, A.D.1
Mar, H.2
Nochlin, D.3
Kimata, K.4
Kato, M.5
Suzuki, S.6
Hassell, J.7
Wight, T.N.8
-
46
-
-
30644465969
-
Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease
-
Tong XK, Nicolakakis N, Kocharyan A, Hamel E. Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. J Neurosci 2005; 25: 11165–74
-
(2005)
J Neurosci
, vol.25
, pp. 11165-11174
-
-
Tong, X.K.1
Nicolakakis, N.2
Kocharyan, A.3
Hamel, E.4
-
48
-
-
13144258773
-
Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin
-
Rockenstein E, Adame A, Mante M, Larrea G, Crews L, Windisch M, Moessler H, Masliah E. Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin. J Neural Transm 2005; 112: 269–82
-
(2005)
J Neural Transm
, vol.112
, pp. 269-282
-
-
Rockenstein, E.1
Adame, A.2
Mante, M.3
Larrea, G.4
Crews, L.5
Windisch, M.6
Moessler, H.7
Masliah, E.8
-
49
-
-
70349847734
-
Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances
-
Thal DR, Capetillo-Zarate E, Larionov S, Staufenbiel M, Zurbruegg S, Beckmann N. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances. Neurobiol Aging 2009; 30: 1936–48
-
(2009)
Neurobiol Aging
, vol.30
, pp. 1936-1948
-
-
Thal, D.R.1
Capetillo-Zarate, E.2
Larionov, S.3
Staufenbiel, M.4
Zurbruegg, S.5
Beckmann, N.6
-
50
-
-
33646759259
-
Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status
-
Bouras C, Kovari E, Herrmann FR, Rivara CB, Bailey TL, von Gunten A, Hof PR, Giannakopoulos P. Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status. J Neuropathol Exp Neurol 2006; 65: 235–44
-
(2006)
J Neuropathol Exp Neurol
, vol.65
, pp. 235-244
-
-
Bouras, C.1
Kovari, E.2
Herrmann, F.R.3
Rivara, C.B.4
Bailey, T.L.5
von Gunten, A.6
Hof, P.R.7
Giannakopoulos, P.8
-
51
-
-
60349096101
-
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease
-
Bourasset F, Ouellet M, Tremblay C, Julien C, Do TM, Oddo S, LaFerla F, Calon F. Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease. Neuropharmacology 2009; 56: 808–13
-
(2009)
Neuropharmacology
, vol.56
, pp. 808-813
-
-
Bourasset, F.1
Ouellet, M.2
Tremblay, C.3
Julien, C.4
Do, T.M.5
Oddo, S.6
LaFerla, F.7
Calon, F.8
-
52
-
-
0038150555
-
Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia
-
Burggraf D, Martens HK, Jager G, Hamann GF. Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia. Thromb Haemost 2003; 89: 1072–80
-
(2003)
Thromb Haemost
, vol.89
, pp. 1072-1080
-
-
Burggraf, D.1
Martens, H.K.2
Jager, G.3
Hamann, G.F.4
-
53
-
-
0034602091
-
Plasminogen activation in experimental permanent focal cerebral ischemia
-
Pfefferkorn T, Wiessner C, Allegrini PR, Staufer B, Vosko MR, Liebetrau M, Bueltemeier G, Kloss CU, Hamann GF. Plasminogen activation in experimental permanent focal cerebral ischemia. Brain Res 2000; 882: 19–25
-
(2000)
Brain Res
, vol.882
, pp. 19-25
-
-
Pfefferkorn, T.1
Wiessner, C.2
Allegrini, P.R.3
Staufer, B.4
Vosko, M.R.5
Liebetrau, M.6
Bueltemeier, G.7
Kloss, C.U.8
Hamann, G.F.9
-
54
-
-
0034703594
-
Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease
-
Leake A, Morris CM, Whateley J. Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease. Neurosci Lett 2000; 291: 201–3
-
(2000)
Neurosci Lett
, vol.291
, pp. 201-203
-
-
Leake, A.1
Morris, C.M.2
Whateley, J.3
-
55
-
-
77957321489
-
Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease
-
Horstmann S, Budig L, Gardner H, Koziol J, Deuschle M, Schilling C, Wagner S. Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease. Int Psychogeriatr 2010; 22: 966–72
-
(2010)
Int Psychogeriatr
, vol.22
, pp. 966-972
-
-
Horstmann, S.1
Budig, L.2
Gardner, H.3
Koziol, J.4
Deuschle, M.5
Schilling, C.6
Wagner, S.7
-
56
-
-
84901930783
-
Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease
-
Mroczko B, Groblewska M, Zboch M, Kulczynska A, Koper OM, Szmitkowski M, Kornhuber J, Lewczuk P. Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease. J Alzheimers Dis 2014; 40: 351–7
-
(2014)
J Alzheimers Dis
, vol.40
, pp. 351-357
-
-
Mroczko, B.1
Groblewska, M.2
Zboch, M.3
Kulczynska, A.4
Koper, O.M.5
Szmitkowski, M.6
Kornhuber, J.7
Lewczuk, P.8
-
57
-
-
69949183657
-
Brain extracellular matrix in neurodegeneration
-
Bonneh-Barkay D, Wiley CA. Brain extracellular matrix in neurodegeneration. Brain Pathol 2009; 19: 573–85
-
(2009)
Brain Pathol
, vol.19
, pp. 573-585
-
-
Bonneh-Barkay, D.1
Wiley, C.A.2
-
58
-
-
77954788631
-
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
-
Stomrud E, Bjorkqvist M, Janciauskiene S, Minthon L, Hansson O. Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease. Alzheimers Res Ther 2010; 2: 20
-
(2010)
Alzheimers Res Ther
, vol.2
, pp. 20
-
-
Stomrud, E.1
Bjorkqvist, M.2
Janciauskiene, S.3
Minthon, L.4
Hansson, O.5
-
59
-
-
84896998770
-
Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer's disease
-
Frings L, Yew B, Flanagan E, Lam BY, Hull M, Huppertz HJ, Hodges JR, Hornberger M. Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer's disease. PLoS ONE 2014; 9: e90814
-
(2014)
PLoS ONE
, vol.9
-
-
Frings, L.1
Yew, B.2
Flanagan, E.3
Lam, B.Y.4
Hull, M.5
Huppertz, H.J.6
Hodges, J.R.7
Hornberger, M.8
-
60
-
-
5644227314
-
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease
-
Karas GB, Scheltens P, Rombouts SA, Visser PJ, van Schijndel RA, Fox NC, Barkhof F. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. NeuroImage 2004; 23: 708–16
-
(2004)
NeuroImage
, vol.23
, pp. 708-716
-
-
Karas, G.B.1
Scheltens, P.2
Rombouts, S.A.3
Visser, P.J.4
van Schijndel, R.A.5
Fox, N.C.6
Barkhof, F.7
-
61
-
-
0025987306
-
The topographic distribution of brain atrophy in Alzheimer's disease
-
Mann DM. The topographic distribution of brain atrophy in Alzheimer's disease. Acta Neuropathol 1991; 83: 81–6
-
(1991)
Acta Neuropathol
, vol.83
, pp. 81-86
-
-
Mann, D.M.1
-
62
-
-
0026098101
-
Alzheimer disease: measuring loss of cerebral gray matter with MR imaging
-
Rusinek H, de Leon MJ, George AE, Stylopoulos LA, Chandra R, Smith G, Rand T, Mourino M, Kowalski H. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology 1991; 178: 109–14
-
(1991)
Radiology
, vol.178
, pp. 109-114
-
-
Rusinek, H.1
de Leon, M.J.2
George, A.E.3
Stylopoulos, L.A.4
Chandra, R.5
Smith, G.6
Rand, T.7
Mourino, M.8
Kowalski, H.9
-
63
-
-
0019427882
-
Morphometric comparison of hippocampal microvasculature in ageing and demented people: diameters and densities
-
Bell MA, Ball MJ. Morphometric comparison of hippocampal microvasculature in ageing and demented people: diameters and densities. Acta Neuropathol 1981; 53: 299–318
-
(1981)
Acta Neuropathol
, vol.53
, pp. 299-318
-
-
Bell, M.A.1
Ball, M.J.2
-
64
-
-
0022966838
-
The correlation of vascular capacity with the parenchymal lesions of Alzheimer's disease
-
Bell MA, Ball MJ. The correlation of vascular capacity with the parenchymal lesions of Alzheimer's disease. Can J Neurol Sci 1986; 13(4 Suppl.): 456–61
-
(1986)
Can J Neurol Sci
, vol.13
, Issue.4
, pp. 456-461
-
-
Bell, M.A.1
Ball, M.J.2
-
65
-
-
34249790312
-
Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well
-
Brown WR, Moody DM, Thore CR, Challa VR, Anstrom JA. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J Neurol Sci 2007; 257: 62–6
-
(2007)
J Neurol Sci
, vol.257
, pp. 62-66
-
-
Brown, W.R.1
Moody, D.M.2
Thore, C.R.3
Challa, V.R.4
Anstrom, J.A.5
-
66
-
-
0025291802
-
Altered angioarchitecture in selected areas of brains with Alzheimer's disease
-
Fischer VW, Siddiqi A, Yusufaly Y. Altered angioarchitecture in selected areas of brains with Alzheimer's disease. Acta Neuropathol 1990; 79: 672–9
-
(1990)
Acta Neuropathol
, vol.79
, pp. 672-679
-
-
Fischer, V.W.1
Siddiqi, A.2
Yusufaly, Y.3
-
67
-
-
67349132699
-
Evidence of angiogenic vessels in Alzheimer's disease
-
Desai BS, Schneider JA, Li JL, Carvey PM, Hendey B. Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm 2009; 116: 587–97
-
(2009)
J Neural Transm
, vol.116
, pp. 587-597
-
-
Desai, B.S.1
Schneider, J.A.2
Li, J.L.3
Carvey, P.M.4
Hendey, B.5
-
68
-
-
3042590902
-
Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis
-
Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004; 84: 869–901
-
(2004)
Physiol Rev
, vol.84
, pp. 869-901
-
-
Bazzoni, G.1
Dejana, E.2
-
69
-
-
78049308423
-
Peripheral inflammatory biomarkers of Alzheimer's disease: the role of platelets
-
Casoli T, Di Stefano G, Balietti M, Solazzi M, Giorgetti B, Fattoretti P. Peripheral inflammatory biomarkers of Alzheimer's disease: the role of platelets. Biogerontology 2010; 11: 627–33
-
(2010)
Biogerontology
, vol.11
, pp. 627-633
-
-
Casoli, T.1
Di Stefano, G.2
Balietti, M.3
Solazzi, M.4
Giorgetti, B.5
Fattoretti, P.6
-
71
-
-
84867466546
-
Elevated plasma endothelial microparticles in Alzheimer's disease
-
Xue S, Cai X, Li W, Zhang Z, Dong W, Hui G. Elevated plasma endothelial microparticles in Alzheimer's disease. Dement Geriatr Cogn Disord 2012; 34: 174–80
-
(2012)
Dement Geriatr Cogn Disord
, vol.34
, pp. 174-180
-
-
Xue, S.1
Cai, X.2
Li, W.3
Zhang, Z.4
Dong, W.5
Hui, G.6
-
72
-
-
8644267728
-
TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms
-
Akahane T, Akahane M, Shah A, Connor CM, Thorgeirsson UP. TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms. Exp Cell Res 2004; 301: 158–67
-
(2004)
Exp Cell Res
, vol.301
, pp. 158-167
-
-
Akahane, T.1
Akahane, M.2
Shah, A.3
Connor, C.M.4
Thorgeirsson, U.P.5
-
73
-
-
33646246165
-
Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia
-
Haglund M, Kalaria R, Slade JY, Englund E. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia. Acta Neuropathol 2006; 111: 430–5
-
(2006)
Acta Neuropathol
, vol.111
, pp. 430-435
-
-
Haglund, M.1
Kalaria, R.2
Slade, J.Y.3
Englund, E.4
-
74
-
-
25144486849
-
Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein
-
Miao J, Xu F, Davis J, Otte-Holler I, Verbeek MM, Van Nostrand WE. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 2005; 167: 505–15
-
(2005)
Am J Pathol
, vol.167
, pp. 505-515
-
-
Miao, J.1
Xu, F.2
Davis, J.3
Otte-Holler, I.4
Verbeek, M.M.5
Van Nostrand, W.E.6
-
75
-
-
35948933394
-
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
-
Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007; 13: 1359–62
-
(2007)
Nat Med
, vol.13
, pp. 1359-1362
-
-
Ray, S.1
Britschgi, M.2
Herbert, C.3
Takeda-Uchimura, Y.4
Boxer, A.5
Blennow, K.6
Friedman, L.F.7
Galasko, D.R.8
Jutel, M.9
Karydas, A.10
Kaye, J.A.11
Leszek, J.12
Miller, B.L.13
Minthon, L.14
Quinn, J.F.15
Rabinovici, G.D.16
Robinson, W.H.17
Sabbagh, M.N.18
So, Y.T.19
Sparks, D.L.20
Tabaton, M.21
Tinklenberg, J.22
Yesavage, J.A.23
Tibshirani, R.24
Wyss-Coray, T.25
more..
-
76
-
-
84934441031
-
Investigating the role of perlecan domain V in post-ischemic cerebral angiogenesis
-
Marcelo A, Bix G. Investigating the role of perlecan domain V in post-ischemic cerebral angiogenesis. Methods Mol Biol 2014; 1135: 331–41
-
(2014)
Methods Mol Biol
, vol.1135
, pp. 331-341
-
-
Marcelo, A.1
Bix, G.2
-
77
-
-
33750951457
-
PECAM-1, a key player in neuroinflammation
-
Kalinowska A, Losy J. PECAM-1, a key player in neuroinflammation. Eur J Neurol 2006; 13: 1284–90
-
(2006)
Eur J Neurol
, vol.13
, pp. 1284-1290
-
-
Kalinowska, A.1
Losy, J.2
|